FARINA, ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.319
EU - Europa 1.455
AS - Asia 712
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
AF - Africa 1
SA - Sud America 1
Totale 4.502
Nazione #
US - Stati Uniti d'America 2.315
IE - Irlanda 511
CN - Cina 375
TR - Turchia 207
IT - Italia 192
SE - Svezia 191
DE - Germania 158
UA - Ucraina 126
GB - Regno Unito 114
SG - Singapore 89
FI - Finlandia 69
FR - Francia 39
CZ - Repubblica Ceca 29
VN - Vietnam 20
BE - Belgio 17
IN - India 8
KR - Corea 8
EU - Europa 7
AU - Australia 4
CA - Canada 4
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
HK - Hong Kong 2
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
ID - Indonesia 1
IL - Israele 1
NL - Olanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 4.502
Città #
Chandler 521
Dublin 511
Jacksonville 511
Boardman 180
Izmir 100
Nanjing 96
Wilmington 83
San Mateo 79
New York 76
Lawrence 67
Princeton 67
Singapore 57
Ashburn 53
Beijing 53
Ann Arbor 52
Dearborn 42
L'aquila 41
Nanchang 37
Milan 33
Shenyang 31
Brno 28
Verona 27
Woodbridge 23
Hebei 22
Tianjin 21
Dong Ket 20
Falls Church 20
Seattle 18
Brussels 17
Des Moines 17
Jinan 15
Mountain View 14
Bremen 13
Helsinki 13
Jiaxing 12
Los Angeles 12
Munich 11
Rome 11
Guangzhou 10
Kunming 10
L’Aquila 10
Norwalk 10
Auburn Hills 9
Changsha 9
Philadelphia 8
Shanghai 8
Hefei 7
Ningbo 7
Dallas 6
Hangzhou 6
Impruneta 6
Kitzingen 6
Taizhou 6
Washington 6
West Jordan 6
Lanzhou 5
San Francisco 5
Changchun 4
Strasbourg 4
Zhengzhou 4
Bologna 3
Catania 3
Pollenza 3
Toronto 3
Altidona 2
Aquila 2
Auckland 2
Berlin 2
Borås 2
Cambridge 2
Cava de' Tirreni 2
Cedar Knolls 2
Central 2
Chieti 2
Fairfield 2
Ferentino 2
Haikou 2
Lanciano 2
Mumbai 2
Redwood City 2
Sora 2
Taiyuan 2
Trieste 2
Amsterdam 1
Aversa 1
Bangkok 1
Belgrade 1
Bratislava 1
Brisbane 1
Bucharest 1
Campobasso 1
Canberra 1
Charlotte 1
Chongqing 1
Cleveland 1
Frankfurt am Main 1
Fremont 1
Frosinone 1
Fuzhou 1
Giaveno 1
Totale 3.223
Nome #
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression. 102
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 98
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 97
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 95
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 95
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 87
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 86
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 82
Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappa B elements 80
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 78
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 77
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 76
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 76
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 75
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 74
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens. 73
fos/jun and octamer-binding protein interact with a common site in a negative element of the human c-myc gene. 73
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. 70
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 70
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 70
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 70
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 69
CELL-SPECIFIC BIFUNCTIONAL ROLE OF JUN ONCOGENE FAMILY MEMBERS ON GLUCOCORTICOID RECEPTOR-DEPENDENT TRANSCRIPTION 69
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 68
Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule 1 (ICAM-1) gene are required for induction of transcription by IFN-gamma 68
AN EARLY RESPONSE OF AN AP1-JUND COMPLEX DURING T-CELL ACTIVATION 68
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 68
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 68
Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. 67
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 66
TrkAIII expression in the thymus 66
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 65
Alternative TrkA splicing and neuroblastoma 65
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced Death of SH-SY5Y Neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, whitin the context of a tumour stem cell-like phenotype 65
Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. 64
Alternative TrkAIII splicing and Cancer 64
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 64
TRASFORMING GROWTH FACTOR-BETA 1 ENHANCES THE INVASIVITY OF HUMAN MDBA-MB-231 BREAST CANCER CELLS BY UP REGULATING UROKINASE ACTIVITY 63
T-cell restricted and unrestricted expression of transfected human interleukin-2 gene: phorbol ester- and calcium-inducible versus constitutive expression. 62
The Alternative TrkAIII splice variant by neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 62
AUTOIMMUNE ANTIGEN KU IS ENRICHED ON OLIGONUCLEOTIDE COLUMNS DISTINCT FROM THOSE CONTAINING THE OCTAMER BINDING PROTEINDNA CONSENSUS SEQUENCE 61
TRANSCRIPTIONAL MODULATION OF THE HUMAN INTERCELLULAR ADHESION MOLECULE GENE I (ICAM-1) BY RETINOIC ACID IN MELANOMA CELLS 60
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 60
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 59
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 59
Alternative TrkA splicing and Cancer 58
Transcriptional regulation of the interleukin 2 gene by glucocorticoid hormones. Role of steroid receptor and antigen-responsive 5'-flanking sequences. 58
Thioredoxin inhibits microvascular endothelial capillary tubule formation 54
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 54
GLUCORTICOID RECEPTOR-MEDIATED SUPPRESSION OF THE INTERLEUKIN 2 GENE EXPRESSION THROUGH IMPAIRMENT OF THE COOPERATIVITY BETWEEN NUCLEAR FACTOR OF ACTIVATED T CELLS AND AP-1 ENHANCER ELEMENTS 53
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 52
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 52
POSITIVE AND NEGATIVE REGULATION OF THE COMPOSITE OCTAMER MOTIF OF THE INTERLEUKIN 2 ENHANCER BY AP-1, OCT-2, AND RETINOIC ACID RECEPTOR 51
Tissue inhibitor of metalloproteinase-2 protection of matrix metalloproteinase-2 from degradation by plasmin is reversed by divalent cation chelator EDTA and the bisphosphonate alendronate 49
Multiple components are required for sequence recognition of the AP1 site in the gibbon ape leukemia virus enhancer. 49
Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer. 49
Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: A pilot study 49
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 48
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 48
A Prospective Study of Intraarterial Infusion Chemotherapy in Advanced WT BRAF Melanoma Patients 48
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 47
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases 46
THE KU COMPLEX IS MODULATED IN RESPONSE TO VIRAL INFECTION AND OTHER CELLULAR CHANGES 44
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 43
PROSTAGLANDIN E2 INHIBITS THE INTERLEUKIN-2 PROMOTER ACTIVITY THROUGH DOWN-REGULATION OF THE OCT-DEPENDENT TRANSCRIPTION OF THE OCTAMER MOTIF 42
A Pilot Study of the Predictive Potential of Chemosensitivity and Gene Expression Assays Using Circulating Tumour Cells from Patients with Recurrent Ovarian Cancer 41
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 40
null 39
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 39
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 36
null 35
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 31
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 30
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 23
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 19
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 12
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 11
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 9
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 8
Totale 4.621
Categoria #
all - tutte 19.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020440 0 0 0 8 10 84 142 19 79 23 9 66
2020/2021581 19 66 0 69 77 21 73 9 68 24 114 41
2021/2022451 33 36 73 27 26 13 12 26 23 11 35 136
2022/20231.460 94 101 35 152 133 151 3 73 649 6 32 31
2023/2024388 49 18 38 41 29 107 1 5 5 12 7 76
2024/2025207 39 27 137 4 0 0 0 0 0 0 0 0
Totale 4.621